IA
LGND icon

Icon Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Icon Advisers’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50,060
Closed -$4.24M – 307
2018
Q4 		$4.24M Sell
50,060
-1,204
-2% -$128K 0.45% 68
2018
Q3 		$8.78M Sell
51,264
-13,752
-21% -$2.07M 0.74% 40
2018
Q2 		$8.4M Hold
65,016
– – 0.64% 52
2018
Q1 		$6.7M Buy
65,016
+34,439
+113% +$3.41M 0.51% 64
2017
Q4 		$2.61M Hold
30,577
– – 0.18% 127
2017
Q3 		$2.6M Hold
30,577
– – 0.18% 154
2017
Q2 		$2.32M Hold
30,577
– – 0.16% 185
2017
Q1 		$2.02M Buy
30,577
+18,434
+152% +$1.21M 0.14% 194
2016
Q4 		$770K Hold
12,143
– – 0.05% 306
2016
Q3 		$773K Buy
12,143
+8,817
+265% +$647K 0.05% 331
2016
Q2 		$247K Hold
3,326
– – 0.02% 359
2016
Q1 		$222K Sell
3,326
-1,443
-30% -$87.7K 0.02% 328
2015
Q4 		$323K Sell
4,769
-25,007
-84% -$1.54M 0.02% 332
2015
Q3 		$1.59M Sell
29,776
-16,280
-35% -$988K 0.11% 174
2015
Q2 		$2.9M Sell
46,056
-7,694
-14% -$420K 0.18% 131
2015
Q1 		$2.59M Sell
53,750
-44,884
-46% -$1.72M 0.15% 135
2014
Q4 		$3.27M Buy
98,634
+49,533
+101% +$1.61M 0.19% 124
2014
Q3 		$1.44M Buy
49,101
+14,427
+42% +$479K 0.08% 179
2014
Q2 		$1.35M Buy
+34,674
New +$1.41M 0.08% 184
2014
Q1 		– Sell
-8,015
Closed -$263K – 335
2013
Q4 		$263K Buy
+8,015
New +$261K 0.02% 264

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Icon Advisers's LGND Position: Q1 2019 in Review

Icon Advisers sold out of Ligand Pharmaceuticals (LGND) in Q1 2019, closing a stake of 50,060 shares — an estimated $4.24M sold.

Icon Advisers first reported a position in LGND in Q4 2013 and held it in 20 quarters. The position peaked at $8.78M in Q3 2018. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

  • Icon Advisers reported no remaining Ligand Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Icon Advisers sold 50,060 Ligand Pharmaceuticals shares in Q1 2019, an estimated $4.24M.
  • Icon Advisers first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 20 quarters.
  • Icon Advisers's Ligand Pharmaceuticals position peaked at $8.78M in Q3 2018.
  • 330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on Icon Advisers's 13F filing for Q1 2019, filed 1 May 2019.